Table 1.
Urinary PyV-Haufen test results in cohorts of kidney transplant recipients with varying clinical signs of PyV replication/activation.
| Groups N (Patients in Group) |
PyV-Haufen Positive N (%) |
PyV Haufen Negative N (%) |
N Patients Tested for PyV-Haufen |
|---|---|---|---|
|
Group 1 N = 581 No PyV activation |
1 (6) | 16 (94) | 17 |
|
Group 2 N = 37 PyV activation with positive decoy-cell tests |
0 (0) | 24 (100) | 24 |
|
Group 3 N = 78 PyV activation with low level BKPy-viremia |
1 (2) | 56 (98) | 57 |
|
Group 4 N = 32 PyV activation with high level BKPy-viremia |
0 (0) | 31 (100) | 31 |
|
Group 5 N = 81 Biopsy proven “definitive” PyVN |
80 (99) | 1 (1) | 81 |
| N Patients tested | 82 | 128 | 210 |
Group definitions are provided above. N refers to the number of patients.